In 2024 I designed and taught a laser powder bed fusion course for engineers from Stryker, one of the largest orthopaedic device makers, through IIT Guwahati’s advanced training program. I expected questions about lasers and parameters. Most of the best questions were about something else: how do you prove, part after part, that the process does what you say it does?
That question is the heart of LPBF in the medical industry. This article sums up what I learned preparing that course and talking with people who make implants for a living.
Why medicine adopted metal AM early
Medical devices were among the first serious production applications of metal additive manufacturing. A few reasons stand out:
- Porous structures for bone ingrowth. Implants such as acetabular cups and spinal cages benefit from a porous surface or body that bone can grow into. AM can print the porous structure and the solid body as one part, with controlled pore size and strut thickness.
- Patient-specific devices. Custom implants, guides and plates can be designed from CT scans of the individual patient. AM makes one-off geometry economical.
- Small parts, high value. Many implants are small enough to nest dozens or hundreds on one build plate, which spreads machine cost.
- Suitable materials. Titanium alloys, especially Ti-6Al-4V ELI, and cobalt-chrome are well established in both conventional and printed implants.
Several major orthopaedic companies now run dedicated AM production. Printed titanium implants are routine products, not experiments.
What device makers need from the process
A qualified, locked process. In regulated manufacturing, a process is validated and then controlled. Machine, software version, parameters, powder specification, reuse scheme, post-processing and inspection are fixed and documented. Changes go through change control. A process engineer’s most important job is often to keep things the same.
Evidence that each part is good. Because many AM defects are internal, inspection matters. CT scanning, witness coupons built alongside parts, and in-process monitoring are all used, depending on the risk. The aim is a body of evidence that ties each part to a build, a machine, a powder lot and test results.
Powder control. For titanium implants, oxygen is the main concern. ELI grades typically limit oxygen to 0.13 wt%, and every reuse cycle can add some. Medical makers need a documented reuse scheme with evidence that it does not affect the device. ASTM F3456 gives a common way to describe one. I covered the economics and the oxygen limits in two earlier articles on this site.
Cleanliness. Porous structures trap powder and processing residues. Removing them, and proving they have been removed, is one of the harder problems in printed implants.
Surface and fatigue. Implants are loaded millions of times. As-built surfaces are rough, and the transition between porous and solid regions concentrates stress. Fatigue testing of the actual design, with its actual surface and heat treatment, is essential.
The regulatory frame
In the United States, the FDA’s 2017 guidance on technical considerations for additive manufactured medical devices sets out what manufacturers should describe and test: device design, software workflow, material controls, post-processing, process validation, and device testing. Similar expectations exist elsewhere. Quality systems follow ISO 13485. For titanium, ASTM F3001 covers Ti-6Al-4V ELI made by powder bed fusion, and ASTM F2924 covers standard Ti-6Al-4V.
None of these standards gives a recipe. They tell you what evidence you need; the manufacturer has to generate it.
Where I see the opportunities
- Better porous design. Lattice and porous structures designed for both bone ingrowth and fatigue, with powder removal designed in.
- Process monitoring that reduces inspection. If monitoring data can reliably flag defective builds, CT inspection could become more targeted and the cost per part could fall.
- Qualified reuse. Moving from conservative fixed reuse limits to evidence-based schemes can save a great deal of powder without compromising safety.
- Faster patient-specific workflows from scan to printed device, while keeping design controls intact.
- New materials, such as tantalum and some resorbable metals, which are being explored but are far less mature.
Advice for engineers moving into medical AM
If you come from aerospace or research AM, as I did, a few things will feel different:
- Documentation is the product. A perfect part without its records is not a shippable device.
- Stability beats optimization. The best parameter set is the validated one, not the newest one.
- Talk to quality and regulatory early. They will shape what you can change and how.
- Respect cleanliness. Powder in a pore is a problem in a way it is not in a bracket.
- Think about the patient. Every decision ends up inside a person. That focus makes the work meaningful.
LPBF has already changed orthopaedics. The next step is making the process cheaper, more predictable and easier to prove, which is exactly the kind of problem that materials and process engineers are good at.
Further reading
- US FDA (2017). Technical considerations for additive manufactured medical devices. Guidance for industry and FDA staff.
- ASTM F3001. Standard specification for additive manufacturing titanium-6 aluminum-4 vanadium ELI with powder bed fusion.
- ASTM F3456-22. Standard guide for powder reuse schema in powder bed fusion processes for medical applications.
- ISO 13485. Medical devices — Quality management systems — Requirements for regulatory purposes.
